Mrs. Amanda A Elfezzazi is a Checotah, Oklahoma based nurse practitioner. Active license number of Mrs. Amanda A Elfezzazi is 215389 in Oklahoma. Her current practice location is 416420 Ensign Ln, Checotah. Patients can reach her at 918-774-5883. Mrs. Amanda A Elfezzazi is APRN-CNP, AGPCNP and her NPI number (Unique professional ID assigned by NPPES) is 1144000944. Mrs. Amanda A Elfezzazi has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Mrs. Amanda A Elfezzazi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1144000944
NPI Enumeration Date:
29 Sep, 2023
NPI Last Update On:
03 Oct, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Amanda A Elfezzazi are as mentioned below.
License Number
Specialization
State
Status
215389
Oklahoma
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mrs. Amanda A Elfezzazi Po Box 1931, Sallisaw, Oklahoma
Zip:
74955-1931
Phone Number:
918-774-5883
Patients can reach Mrs. Amanda A Elfezzazi at 416420 Ensign Ln, Checotah, Oklahoma or can call to book an appointment on 918-774-5883.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.